• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1500275-15
Device Problem Malposition of Device (2616)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/31/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: guide catheter: 6f; 2.5x38mm and 2.5x12mm xience sierra stents; heparin.The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that on (b)(6) 2018, the patient presented with a recent non-st elevated myocardial infarction (nstemi).A percutaneous intervention was initiated and a predilatation was performed in the proximal right coronary artery (rca), heavily calcified lesion.A 2.5x38mm xience sierra stent was implanted.Post-implantation, an edge dissection was noted.As treatment, a 2.5x12mm stent was implanted.Following, a 2.75x15mm xience sierra, advanced to the rca.Due to the lesions severe calcification, the stent jumped during placement and was implanted too distally, however, still remained at the lesion site.As treatment, another stent was implanted, overlapping the 2.75x15mm xience sierra, to cover the entire lesion site.The event resolved.No additional information was provided regarding this issue.
 
Manufacturer Narrative
Internal file number - (b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties and treatment appear to be related to circumstances of the procedure as it is likely the device interacted with the heavily calcified lesion causing the stent to move during placement (inaccurate delivery) and additional therapy/non-surgical treatment.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8344601
MDR Text Key136302974
Report Number2024168-2019-01149
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Remedial Action Other
Type of Report Initial,Followup
Report Date 03/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/15/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/23/2021
Device Catalogue Number1500275-15
Device Lot Number8101541
Was Device Available for Evaluation? No
Date Manufacturer Received02/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age44 YR
Patient Weight100
-
-